Immunotherapy in Kidney Cancer
0 Visualizzazioni
• 06/26/23
0
0
Incorporare
administrator
Iscritti
Thomas Hutson, DO, PharmD, FACP; James J. Hsieh, MD, PhD; and Martin H. Voss, MD, explain the clinical rationale for immunotherapeutic approaches in the treatment of renal cell carcinoma and the current role for immunotherapy agents.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti